Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
Clinical trial NCT05901818 · RECRUITING
Trial details
- NCT number
- NCT05901818
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2027-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.